AssetMark Inc
ADPT icon

AssetMark Inc’s Adaptive Biotechnologies ADPT Stock Holding History

AssetMark Inc’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$197K Buy
9,179
+4,758
+108% +$72.9K ﹤0.01% 1444
2026
Q1 		$61.4K Buy
4,421
+1,401
+46% +$22.3K ﹤0.01% 1686
2025
Q4 		$49K Buy
3,020
+2,708
+868% +$44.2K ﹤0.01% 1729
2025
Q3 		$4.67K Buy
312
+111
+55% +$1.35K ﹤0.01% 2367
2025
Q2 		$2.34K Buy
+201
New +$1.83K ﹤0.01% 2382
2024
Q2 		– Sell
-80
Closed -$257 – 2099
2024
Q1 		$257 Sell
80
-4,861
-98% -$18.8K ﹤0.01% 1774
2023
Q4 		$24.2K Buy
4,941
+1,498
+44% +$6.83K ﹤0.01% 1269
2023
Q3 		$18.8K Sell
3,443
-622
-15% -$4.11K ﹤0.01% 1250
2023
Q2 		$27.3K Buy
4,065
+1,462
+56% +$10.9K ﹤0.01% 1177
2023
Q1 		$23K Buy
2,603
+575
+28% +$5.07K ﹤0.01% 1176
2022
Q4 		$15.5K Buy
2,028
+625
+45% +$4.86K ﹤0.01% 1246
2022
Q3 		$10K Buy
1,403
+331
+31% +$3.12K ﹤0.01% 1222
2022
Q2 		$9K Buy
1,072
+827
+338% +$7.27K ﹤0.01% 1227
2022
Q1 		$3K Buy
+245
New +$3.85K ﹤0.01% 1339
2021
Q2 		– Sell
-43
Closed -$2K – 1310
2021
Q1 		$2K Buy
+43
New +$2.33K ﹤0.01% 1152

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AssetMark Inc's ADPT Position: Q2 2026 in Review

AssetMark Inc increased its Adaptive Biotechnologies (ADPT) stake by 108% in Q2 2026, buying an estimated $72.9K and bringing the position to 9,179 shares worth $197K. The position accounts for ﹤0.01% of the portfolio, ranked #1444.

AssetMark Inc first reported a position in ADPT in Q1 2021 and has held it in 15 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • AssetMark Inc held 9,179 shares of Adaptive Biotechnologies worth $197K as of Q2 2026.
  • AssetMark Inc bought 4,758 Adaptive Biotechnologies shares in Q2 2026, an estimated $72.9K.
  • Adaptive Biotechnologies made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #1444 holding.
  • AssetMark Inc first reported a position in Adaptive Biotechnologies in Q1 2021 and has held it in 15 quarters since.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.